Tumor antigen-specific CD4+ T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies (Q38196935)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 2014

Language	Label	Description	Also known as
English	Tumor antigen-specific CD4+ T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies	scientific article published on April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

1 reference

Europe PubMed Central

Tumor antigen-specific CD4+ T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Maria Pia Protti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24641502%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Giulia Di Lullo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24641502%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

L De Monte

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24641502%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

1 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Tissue Antigens

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24641502%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

83

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24641502%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24641502%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

237-246

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24641502%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Accessories to the crime: functions of cells recruited to the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Innate and adaptive immune cells in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Lymphocytes in cancer development: polarization towards pro-tumor immunity

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

The immune contexture in human tumours: impact on clinical outcome

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Differentiation of effector CD4 T cell populations (*)

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

The unique features of Th9 cells and their products

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

The good, the bad and the ugly - TFH cells in human health and disease

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

The use of bioinformatics for identifying class II-restricted T-cell epitopes

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

CD4+ T cell responses to SSX-4 in melanoma patients

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Endosomal proteases influence the repertoire of MAGE-A3 epitopes recognized in vivo by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Human T(H)17 immune cells specific for the tumor antigen MAGE-A3 convert to IFN-γ-secreting cells as they differentiate into effector T cells in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Profound tumor-specific Th2 bias in patients with malignant glioma

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Interleukin 22-producing CD4+ T cells in malignant pleural effusion

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

CD4+ T effectors specific for the tumor antigen NY-ESO-1 are highly enriched at ovarian cancer sites and coexist with, but are distinct from, tumor-associated Treg

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Adoptive immunotherapy of cancer using CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

The blockade of immune checkpoints in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Analysis of CD4+ T-Cell Responses to a Novel -Fetoprotein-Derived Epitope in Hepatocellular Carcinoma Patients

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

MAGE-A3161–175 contains an HLA-DRβ4 restricted natural epitope poorly formed through indirect presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FTAN.12329

21 January 2018

Identifiers

10.1111/TAN.12329

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24641502%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24641502%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38196935&oldid=1746773965"